KameleonPharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KameleonPharma
Largest movements
- Cash +€20,326
up €20,326 (+79.3%), from €25,636 to €45,962
mainly Net result for the year (+€18,308) and Receivables within one year (+€6,784)
- Deferred charges and accrued income +€9,542
up €9,542 (+786%), from €1,214 to €10,756
- Receivables within one year -€6,784
down €6,784 (-68.9%), from €9,850 to €3,066
of which Trade receivables: -€9,618
- Tangible fixed assets -€4,166
down €4,166 (-31.6%), from €13,178 to €9,012
of which Plant, machinery and equipment: -€3,627
- Stocks and contracts -€1,894
down €1,894 (-55.3%), from €3,425 to €1,531
- Reserves +€18,308
up €18,308 (+55.9%), from €32,757 to €51,064
- Debts after one year -€2,757
down €2,757 (-53.7%), from €5,135 to €2,379
- Tax, wage and social debts +€1,467
up €1,467 (+27.6%), from €5,311 to €6,778
- Other debts -€1,460
no longer reported in 2025 (was €1,460)
- Trade debts +€927
up €927 (+416%), from €223 to €1,150
- Gross operating margin +€17,214
up €17,214 (+117%), from €14,713 to €31,928
- Taxes +€5,065
up €5,065 (+139%), from €3,641 to €8,706
- Depreciation -€1,030
down €1,030 (-27.3%), from €3,767 to €2,737
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €53,878 | €70,327 | +€16,450 | +30.5% |
| Fixed assets | 21/28 | €13,753 | €9,012 | -€4,741 | -34.5% |
| Intangible fixed assets | 21 | €575 | - | -€575 | |
| Tangible fixed assets | 22/27 | €13,178 | €9,012 | -€4,166 | -31.6% |
| Land and buildings | 22 | €7,090 | €6,551 | -€539 | -7.6% |
| Plant, machinery and equipment | 23 | €6,087 | €2,460 | -€3,627 | -59.6% |
| Current assets | 29/58 | €40,125 | €61,316 | +€21,191 | +52.8% |
| Stocks and contracts in progress | 3 | €3,425 | €1,531 | -€1,894 | -55.3% |
| Stocks | 30/36 | €3,425 | €1,531 | -€1,894 | -55.3% |
| Amounts receivable within one year | 40/41 | €9,850 | €3,066 | -€6,784 | -68.9% |
| Trade receivables | 40 | €9,618 | - | -€9,618 | |
| Other amounts receivable | 41 | €232 | €3,066 | +€2,834 | +1,219% |
| Cash at bank and in hand | 54/58 | €25,636 | €45,962 | +€20,326 | +79.3% |
| Deferred charges and accrued income | 490/1 | €1,214 | €10,756 | +€9,542 | +786% |
| Total equity and liabilities | 10/49 | €53,878 | €70,327 | +€16,450 | +30.5% |
| Equity | 10/15 | €38,957 | €57,264 | +€18,308 | +47.0% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €32,757 | €51,064 | +€18,308 | +55.9% |
| Distributable reserves | 133 | €32,757 | €51,064 | +€18,308 | +55.9% |
| Amounts payable | 17/49 | €14,921 | €13,063 | -€1,858 | -12.5% |
| Amounts payable after more than one year | 17 | €5,135 | €2,379 | -€2,757 | -53.7% |
| Financial debts | 170/4 | €5,135 | €2,379 | -€2,757 | -53.7% |
| Amounts payable within one year | 42/48 | €9,647 | €10,684 | +€1,037 | +10.8% |
| Current portion of amounts payable after more than one year | 42 | €2,653 | €2,757 | +€103 | +3.9% |
| Trade debts | 44 | €223 | €1,150 | +€927 | +416% |
| Suppliers | 440/4 | €223 | €1,150 | +€927 | +416% |
| Taxes, remuneration and social security | 45 | €5,311 | €6,778 | +€1,467 | +27.6% |
| Taxes | 450/3 | €5,311 | €6,778 | +€1,467 | +27.6% |
| Other amounts payable | 47/48 | €1,460 | - | -€1,460 | |
| Accrued charges and deferred income | 492/3 | €139 | - | -€139 | |
| Non-recurring operating income | 76A | - | €1,346 | +€1,346 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,767 | €2,737 | -€1,030 | -27.3% |
| Other operating charges | 640/8 | €1,919 | €1,720 | -€198 | -10.3% |
| Gross operating margin | 9900 | €14,713 | €31,928 | +€17,214 | +117% |
| Operating profit (loss) | 9901 | €9,028 | €27,470 | +€18,442 | +204% |
| Financial income | 75/76B | €125 | €1 | -€124 | -99.4% |
| Recurring financial income | 75 | €125 | €1 | -€124 | -99.4% |
| Financial charges | 65/66B | €676 | €458 | -€218 | -32.3% |
| Recurring financial charges | 65 | €676 | €458 | -€218 | -32.3% |
| Profit (loss) for the period before taxes | 9903 | €8,477 | €27,013 | +€18,536 | +219% |
| Income taxes | 67/77 | €3,641 | €8,706 | +€5,065 | +139% |
| Profit (loss) for the period | 9904 | €4,836 | €18,308 | +€13,471 | +279% |
| Profit (loss) for the period to be appropriated | 9905 | €4,836 | €18,308 | +€13,471 | +279% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.